OT-C001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OT-C001, covering 2025-06-29 to 2025-06-29. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human Study to Assess OT-C001 (Amplified/Activated Allogenic Natural Killer Cells) in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma [Phase 1]